These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27250608)

  • 1. [Beta-blockers and chronic obstructive pulmonary disease].
    Sova M; Kamasová M; Václavík J; Sovová E; Hajdová L; Kolek V
    Vnitr Lek; 2016 Apr; 62(4):305-7. PubMed ID: 27250608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
    Mersfelder TL; Shiltz DL
    Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
    Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
    Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
    Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
    Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
    Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
    Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of beta-blockers in patients with COPD.
    Andrus MR; Holloway KP; Clark DB
    Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.
    Rutten FH
    Future Cardiol; 2011 Jan; 7(1):43-53. PubMed ID: 21174509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
    Rasmussen DB; Lange P; Jensen MT
    Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
    Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
    Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
    Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can beta-blockers be used for people with COPD?
    Drug Ther Bull; 2011 Jan; 49(1):2-5. PubMed ID: 21220252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Blockers, heart disease and COPD: current controversies and uncertainties.
    Baker JG; Wilcox RG
    Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Usage of beta-adrenolytic agents in patients with chronic pulmonary obstructive disease].
    Bułdak Ł; Duława A; Krysiak R; Okopień B
    Pol Merkur Lekarski; 2008 Feb; 24(140):121-4. PubMed ID: 18637263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Controversies and dilemmas on the use of beta-blockers in treatment of associated cardiovascular disease in patients with chronic obstructive pulmonary disease].
    Pescaru C; Tudorache V; Oancea C
    Pneumologia; 2010; 59(1):27-30. PubMed ID: 20432790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fewer COPD exacerbations with beta blockade].
    Urban & Vogel
    MMW Fortschr Med; 2015 Sep; 157(15):1. PubMed ID: 26349691
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
    Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
    Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
    Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
    Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
    Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ;
    Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Under-utilisation of β-blockers in patients with acute coronary syndrome and comorbid chronic obstructive pulmonary disease.
    Kratzer L; Noakes P; Baumwol J; Wrobel JP
    Intern Med J; 2018 Aug; 48(8):931-936. PubMed ID: 29573074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-blockers in COPD: A systematic review based on recent research.
    Li XF; Mao YM
    Life Sci; 2020 Jul; 252():117649. PubMed ID: 32275936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.